Graham K Cooper is of Beam Therapeutics Inc.. Currently has a direct ownership of 0 shares of BEAM, which is worth approximately $0. The most recent transaction as insider was on Jul 06, 2021, when has been sold 2,614 shares (Common Stock) at a price of $122.27 per share, resulting in proceeds of $319,614. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

GRAHAM K COOPER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 06 2021
SELL
Open market or private sale
$319,614 $122.27 p/Share
2,614 Reduced 100.0%
0 Common Stock
Jul 06 2021
BUY
Exercise of conversion of derivative security
$44,438 $17.0 p/Share
2,614 Added 50.0%
2,614 Common Stock
Jun 28 2021
SELL
Open market or private sale
$1,292,549 $107.31 p/Share
12,045 Reduced 100.0%
0 Common Stock
Jun 28 2021
BUY
Exercise of conversion of derivative security
$204,765 $17.0 p/Share
12,045 Added 50.0%
12,045 Common Stock

Also insider at

NUVB
Nuvation Bio Inc. Healthcare
AMTI
Applied Molecular Transport Inc. Healthcare
UBX
Unity Biotechnology, Inc. Healthcare
KZR
Kezar Life Sciences, Inc. Healthcare
GKC

Graham K Cooper

Cambridge, MA

Track Institutional and Insider Activities on BEAM

Follow Beam Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BEAM shares.

Notify only if

Insider Trading

Get notified when an Beam Therapeutics Inc. insider buys or sells BEAM shares.

Notify only if

News

Receive news related to Beam Therapeutics Inc.

Track Activities on BEAM